JPMorgan Chase & Co. Boosts Stake in Ultralife Co. (NASDAQ:ULBI)

JPMorgan Chase & Co. increased its position in Ultralife Co. (NASDAQ:ULBI) by 250.8% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 47,458 shares of the technology company’s stock after purchasing an additional 33,929 shares during the quarter. JPMorgan Chase & Co. owned approximately 0.29% of Ultralife worth $429,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently made changes to their positions in ULBI. Barclays PLC grew its stake in shares of Ultralife by 21.3% in the 3rd quarter. Barclays PLC now owns 13,395 shares of the technology company’s stock worth $121,000 after buying an additional 2,355 shares during the last quarter. Juncture Wealth Strategies LLC purchased a new stake in shares of Ultralife in the third quarter worth $165,000. Jane Street Group LLC bought a new position in shares of Ultralife during the third quarter valued at $166,000. Connor Clark & Lunn Investment Management Ltd. raised its position in shares of Ultralife by 15.5% in the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 157,330 shares of the technology company’s stock worth $1,422,000 after purchasing an additional 21,140 shares during the last quarter. Finally, Geode Capital Management LLC grew its position in Ultralife by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 232,681 shares of the technology company’s stock valued at $2,104,000 after purchasing an additional 2,835 shares during the last quarter. 30.68% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

ULBI has been the subject of several recent analyst reports. Benchmark reaffirmed a “buy” rating and issued a $14.00 target price on shares of Ultralife in a report on Friday, November 15th. StockNews.com cut Ultralife from a “strong-buy” rating to a “buy” rating in a research report on Thursday, October 3rd.

Ultralife Price Performance

NASDAQ ULBI opened at $7.77 on Thursday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.62 and a current ratio of 3.30. The company has a market capitalization of $129.22 million, a price-to-earnings ratio of 14.13 and a beta of 0.96. The stock has a 50-day moving average of $7.65 and a 200 day moving average of $8.94. Ultralife Co. has a one year low of $6.63 and a one year high of $13.39.

Ultralife Profile

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.